Dr Nunzio Bottini (San Diego), the first of the invited speakers opened the session of talks with a tour de force, describing the role of fibroblast like synoviocytes (FLS) in the pathogenesis of rheumatoid arthritis (RA). He explained how his research has identified and validated the role of the transmembrane protein tyrosine phosphatase, PTPRS, in modulating FLS behaviour via the proteoglycan switch mechanism. This will provide an exciting alternative potential therapeutic mechanism to those that use traditional immunosuppressive agents.
Victor Martinez (UCL) followed with a short talk describing the influence of CLEC-2 receptor activation on extracellular matrix (ECM) deposition by fibroblastic reticular cells and the influence this has on the delicate internal architecture and functional capacity of lymph nodes.
The role of ER stress in disruption of collagen synthesis and deposition was explored by Dr Adam Pickard (Manchester) and Dr Afshan Dean (Glasgow). Dr Pickard described the interplay between circadian rhythm, collagen chaperone molecules HSPA5 and 4-PBA and Type I collagen homeostasis, whilst Dr Dean focussed on the effect of defective collagen IV deposition in basement membranes and how supplementation with chemical chaperones PBA and TUDCA can ameliorate the clinical symptoms in a tissue specific manner.
Professor Kim Midwood (Oxford) posed the question 'Is the matrix playing an active role in driving inflammation?' With much research focused on pathogen pattern recognition in the host and its role in reactive inflammatory response, less is understood about the process in situations of sterile inflammation. Using tenascin-C as an example of a matrix protein which is upregulated in non-pathogen associated tissue injury, Prof Midwood described how this molecule plays a role in driving site specific inflammation via induction of inflammatory cytokine synthesis and stimulates production of anti-self antibodies subsequent to citrullination. This protein, which has already shown promise as a biomarker for predicting RA development in clinically asymptomatic patients and as a prognostic marker in primary and metastatic neoplastic disease, may offer a new avenue for treating conditions such as RA.
Session 2. Matrix Pharmacology (1). Chairs: Dr Samantha Arokiasamy and Prof George Bou-Gharios
The second session opened with Giulia De Rossi (QMUL, UK) showing that inhibition of syndecan-2 can reduce neo-vascularisation in macular degeneration. Christopher Schultz (also from QMUL) demonstrated that latent progranulin can serve as a chondrogenic and anti-inflammatory treatment for arthritis. The third speaker Rens de Groot (ICL) presented work comparing COMP proteolysis by ADAMTS7 and ADAMTS4, whilst David Wilkinson (Newcastle) delivered the penultimate talk on the role of transmembrane serine proteinases in osteoarthritis.
The Sir John Scott lecture was given by Elena Rainero (University of Sheffield) who won the BSMB young investigator award, which was presented by Graham Riley. Dr Rainero has uncovered that ligand bound integrins are internalised at fibrillary adhesions located under the nucleus. This internalisation is regulated by tensins -1, -2, -3 as well as the class II Arf4. Suppression of any of these, disrupts the flow of ligand bound integrins. Dr Jessica Bertrand (University Hospital Magdeburg) described the regulatory role syndecan-4 plays in osteoarthritis (OA), mediating articular chondrocytes sensitivity to WNT signalling.
Dr Blandine Poulet (Liverpool) presented data on fibrillin-1 expression patterns in trauma induced and spontaneous OA models and demonstrated joint specific changes in expression from the pericellular expression pattern in articular and growth plate chondrocytes of healthy joints.
Dr Richa Garva (Manchester) returned to the theme of circadian changes in tendon homeostasis addressed earlier, with identification of distinct temporal differences in expression of genes responsible for synthesis, trafficking and degradation of a small pool of 'sacrificial' collagen.
Dr Richard Stratton (UCL) described the identification of genetic variants in the LEPREL1 gene, responsible for encoding prolyl 3-hydroxylase 2, and their role in inappropriate collagen synthesis in dermal fibroblasts. LEPREL1 deletion was shown to be protective against pathological fibrosis.
Dr Tero Jarvinen (University of Tampere, Finland) gave a fascinating talk on his work developing CAR peptide, a 9 amino acid sequence homologous to the heparin binding site of BMP4 which can be conjugated to therapeutic molecules such as decorin to target delivery to areas of active angiogenesis, to accelerate tissue regeneration and minimise scar tissue formation. The talks given by the early career researchers evidenced the great breadth of novel research being done in matrix biology. Victoria Juskaite (ICL) presented her work in unravelling the redistribution and novel collagen induced activation mechanism of the receptor tyrosine kinase DDR1. Richa Garva (Manchester) discussed how the chronomatrix is regulated by proteins controlled by the circadian rhythm. His data illustrated that day and night proteins provide a regulatory control for procollagen secretion. Neil Marr presented how ageing can affect tendon stem progenitor cells and discussed a unique population of tendon stem cells within the interfascicular matrix. Sara Falcone presented novel results indicating that a point mutation in the gene which encodes the laminin alpha-5 chain can cause nephrotic syndrome in a mouse model. The talks were concluded by a presentation by Michele Scotto di Masse (Liverpool) who spoke of the effects of ageing on Col1a1 in lung fibroblasts. The final session of the conference started with John Marshall (QMUL) delivering a riveting account of the past, present, and future of targeting integrin avb6 to treat cancers. Annele Saino (Turku, Finland) demonstrated how decorin-mediated mechanisms can be targeted for oncosuppressive treatments in breast cancer. Francesco Dell'Accio (QMUL) delivered an impromptu performance, discussing Suzanne Eldridge's work on agrin as an inhibitor of the canonical WNT signalling cascade. Next, Edward Horton (Copenhagen, Denmark) gave excellent insight into how targeting tissue-specific fibroblast-derived matrix components can be used to inhibit metastasis. The final talk of the conference was delivered by Oliver Pearce (QMUL), describing his work on the development of a matrix index that tracked evolving tumour microenvironments, which can now inform 3D in vitro models of tumour progression.
To close the meeting, awards were presented to, Victoria Juskaite (best oral presentation), Sean Giblin (Oxford) and Saima Ahmed (Sheffield), (best poster presentations). With the conference being a huge success, it came as no surprise that James Whiteford received huge applause for putting together an excellent conference, and attracting an incredible group of researchers.
Introduction Syndecan-4 (Sdc-4) is an important regulator of cartilage degradation and therefore plays a significant role in osteoarthritis (OA). Sdc-4 is a heparan sulfate proteoglycan and is known to be upregulated during OA. Syndecans can be shed by peptidases e.g. matrix metallopeptidases (MMPs). We hypothesize that Sdc-4 shedding impacts on signal transduction under inflammatory conditions. Materials and Methods Samples have been collected from OA patients undergoing total knee replacement surgery. Shed Sdc-4 levels in synovial fluid have been determined via Sdc-4 ELISA (IBL). RNA extracted from articular cartilage and synovial membrane has been assessed via RT-qPCR for specific mRNA levels. In vitro analysis has been performed by stimulating chondrocytes (C28/I2) with previously activated sheddases (MMP3/9, ADAM17) and/or IL-1b followed by either Sdc-4 ELISA or Western Blot. Furthermore, protein localization has been examined by immunohistochemistry. Levels of active MMP9 have been characterized via Zymography. Results Analysis of synovial fluid from OA patients revealed an increase of shed Sdc-4 depending on the Kellgren-Lawrence Score. MMP3, MMP9 and ADAM17 were able to shed Sdc-4 in vitro. However, MMP9 displayed the highest shedding activity. Expression levels of MMP9 and Sdc-4 showed a significant upregulation in articular cartilage with increasing OA severity. The other sheddases as well as the expression levels of Sdc-4 and MMP9 in synovium did not correlate with OA severity. Upregulation of Sdc-4 was confirmed using IHC. Active MMP9 was present in synovial fluid at all stages of OA, but did not correlate with the degree of OA severity. Upon MMP9 induced Sdc-4 shedding, chondrocytes showed reduced IL-1b dependent phosphorylation of ERK in vitro. Furthermore, adding soluble Sdc-4 to chondrocytes seems to delay IL-1b signaling in chondrocytes. Discussion MMP9 expression displays a significant upregulation with OA progression in cartilage and exhibits the highest shedding activity in vitro. Therefore MMP9 is most likely to be responsible for Sdc-4 shedding in vivo. Soluble Sdc-4 seems to be a decoy receptor as it delays IL-1b signaling. MMP9 induced shedding in vitro results in a desensitization of chondrocytes towards IL-1b signaling, which might indicate a protective role of Sdc-4 shedding in the OA joint.
Introduction Cartilage injuries are a predisposing factor for the developmental of osteoarthritis. The question of whether articular cartilage can repair itself (intrinsic repair), is an important one. Although, historically believed to be a tissue of poor reparative capacity, many recent studies in human and animals show that repair does occur. The mechanisms of this repair are unknown. Since mesenchymal stem cells (MSCs) are known to migrate to the injury site, we investigated whether MSCs in the synovial fluid and the bone marrow (SF-and BM MSCs) respond to traumatic cartilage injury and the mechanism by which this occurs. Materials and Methods SF and BM MSCs isolated from the bovine metacarpophalangeal joints were expanded by monolayer culture. Injury conditioned media (IJCM) was produced by incubation of freshly chopped articular cartilage with serum-free media (DMEM +0.1% BSA) for 24 h. Migration was determined using classical Transwell TM , scratch and cell exclusion zone assays. Results MSCs demonstrated significant levels of migration (P < 0.001) to freshly injured articular cartilage compared to non-injured or devitalised cartilage. IJCM stimulated significant SF MSC [75%AE(6%; P < 0.0001) compared to 14% AE(1%) in control)] and BM MSC [87%AE(4%; P < 0.0001) compared to 48%AE(7%)] migration shown by reduction in wound width in scratch assays which require injuring the cell layer. This migration was significantly (P < 0.0001) inhibited by neutralising antibodies to CXCL12 and TGFb3 and CXCR4 small-molecule inhibitor AMD3100. IJCM did not stimulate SF MSC migration in cell exclusion zone assays where no 'wound' was created. Migration was only observed in this system when cell injury was created (by scrapping off cells) close to the cell exclusion zone. Cell injury released rapidly metabolised ATP (189 lM at 30 min and 24 lM at 4 h after injury) determined by ATP bioluminescence assay. This was further validated by addition of stable ATPcS or UTPcS (250 lm) with IJCM which stimulated significant SF MSC migration in the cell exclusion zone assays suggesting a role for a putative P2 receptor. SF MSC migration in scratch assays could also be completely inhibited by addition of P2 purine receptor antagonist suramin. Discussion We showed that cartilage, following injury, releases ATP, TGFb3 and CXCL12. ATP acted transiently to prime the SF MSCs while TGFb3 and CXCL12 stimulated cell homing.
Introduction The discoidin domain receptors, DDR1 and DDR2, are intriguing receptor tyrosine kinases (RTKs) that signal in response to collagen with unusually delayed autophosphorylation kinetics. Both DDRs play important roles in development and regulate cell adhesion, migration, invasion, proliferation, and survival. The DDRs are attractive drug targets for organ fibrosis, atherosclerosis, arthritis and various forms of cancer, but very little is understood about how collagen binding translates to DDR activation. Classical RTKs are activated through ligandinduced dimerisation. However, the DDRs are constitutive, non-covalent dimers and are unlikely to signal at the level of dimers. We hypothesised that collagen binding induces lateral association (clustering) of DDR dimers on the cell membrane. Materials and Methods Different types of signalling-incompetent DDR1 mutants ('receiver'), including enforced covalent receiver dimers, were co-expressed with functional DDR1 ('donor'). Phosphorylation of receiver DDR1 by donor DDR1 was monitored by SDS-PAGE and Western blotting, or by immunofluorescence. Results Here we show that receiver DDR1 constructs are phosphorylated by donor DDR1 in response to collagen. Making use of enforced covalent DDR1 dimerisation, which does not affect receptor activation, we demonstrate that receiver dimers are phosphorylated in trans by the donor. This requires kinase activity of the donor but not that of the receiver. Phosphorylation in trans is independent of ectodomain contacts and specific intracellular regions, but is abolished by mutations in the transmembrane domain. Ligand multivalency or a specific mode of DDR1 activation is not required for phosphorylation in trans. Furthermore, collagen binding induces redistribution of DDR1 into a more compact structure, and mutant DDR1 that cannot bind collagen is recruited to collagen-coated beads when co-expressed with functional receptor. Discussion Collagen binding induces recruitment of DDR1 into signalling clusters and phosphorylation between DDR1 dimers, which is consistent with a mechanism of DDR1 activation by receptor clustering.
Introduction The metalloprotease ADAMTS7 may have a pathophysiological role in coronary artery disease (CAD) and osteoarthritis, however, its physiological role and target substrates remain unclear. The ADAMTS7 gene is a susceptibility locus for CAD and studies in rodents suggest it functions in the injured/diseased arterial wall. A role for ADAMTS7 in cartilage homeostasis through the proteolysis of COMP has also been proposed. In this setting, ADAMTS7 was reported to be significantly increased in human arthritic cartilage and synovium and knockdown of Adamts7 in mice attenuated degradation of cartilage. However, numerous proteases can proteolyse COMP and which of these proteolytic reactions are physiologically relevant has not been clearly established. Our aim was to express and purify ADAMTS7 and assess its proteolysis of various matrix proteins. Materials and Methods COMP, ADAMTS4, 5 and 7 and truncated variants thereof were expressed in HEK293
International Journal of Experimental Pathology, 2017, 98, A1-A14 (ADAMTS) or S2 cells (COMP). Ion exchange and affinity chromatography were used for purification. Proteolysis was analysed by Western Blotting (WB). Results WB analysis of ADAMTS7 confirmed it is a proteoglycan, as treatment with chondroitinase AC or ABC caused a large reduction in molecular weight (MW). We also investigated a low MW band that was suspected to result from autolysis. This was confirmed, as when ADAMTS7 was inactivated by mutagenesis of the active site (E389Q) or prevention of Pro-domain removal, this autolysis band disappeared. N-terminal sequencing of the product of autolysis revealed that the scissile bond is a Glu-Ala bond in a surface exposed loop in the Spacer domain. A comparison of the relative susceptibility of COMP to proteolysis by ADAMTS7 and ADAMTS4 revealed that this substrate is cleaved >1000 fold more efficiently by ADAMTS4 than by ADAMTS7. Negligible proteolysis of COMP by ADAMTS5 was seen. Discussion This is the first time a scissile bond for ADAMTS7 is reported and, interestingly, Glu-Ala is also a preferred bond for proteolysis by ADAMTS1, 4 and 5. We shed light therefore on the cleavage site specificity of ADAMTS7 and also show its proteolysis of COMP is inefficient compared to that by ADAMTS4. The latter cleaved COMP with remarkable efficiency, which is under further investigation, as is the substrate specificity of ADAMTS7.
Ageing-induced osteoarthritis in nrf2 knockout mice Introduction Osteoarthritis (OA) is a highly prevalent and debilitating disease. Despite the significance of this disease, there is currently no effective treatment available to patients. Care is largely palliative, restricted to lifestyle modification, analgesia, and anti-inflammatories to reduce pain and maintain mobility. Oxidative stress has been implicated in the pathogenesis of multiple diseases, including OA. Nrf2, a regulator of the anti-oxidant defence system, has been shown to be an influential factor in the progression of OA in posttraumatic models. However, this has not been established in an ageing model. This study aims to examine the significance of nrf2 in the development of primary osteoarthritis in an ageing model. Materials and Methods Left knees were harvested from one year old, male, C57BL/6, nrf2 knockout (KO) and wild type (WT) mice. Knees were scanned using micro-computed tomography (micro-CT) to assess bone volume changes and tibial epiphysis trabecular characteristics. Assessment of the articular cartilage (AC) was carried out using histological staining with toluidine blue (0.04%). AC was scored using an Osteoarthritis Research Society International (OARSI) recommended scoring system. All statistics used an unpaired student's t-test and were expressed as mean AE SEM. n = 10 for each group and P ≤ 0.05 was considered statistically significant.
Results Analysis of micro-CT revealed no significant differences in volume or trabecular characteristics within the tibia or menisci, however, a statistically significant increase in mineralised tissue was found within the central joint space in nrf2 KO mice (P = 0.0298). Histological analysis found no significant changes in AC structure between groups. On inspection of the central joint space there was an abnormal increase in stain of the cruciate ligaments, which correlated with findings from micro-CT analysis. Discussion This study has shown that nrf2 knockdown has a limited effect on the progression of ageing-induced OA in mice, which contradicts previous studies using post-traumatic OA models. These results suggest differing pathways in the pathogenesis of OA between models and will potentially require different therapeutic targets to slow the disease progression.
Introduction Nephrotic syndrome (NS) is a heterogeneous group of disorders characterised by renal and extra renal manifestations. Classic symptoms of NS include severe proteinuria and hypoalbuminemia, oedema and hyperlipidemia. Genetic studies of hereditary forms of NS have led to the identification of proteins playing a crucial role in slit diaphragm signalling, regulation of actin cytoskeleton dynamics and cell-matrix interactions. As part of the MRC Harwell ageing screen, a missense mutation was identified in the gene Lama5 coding for the laminin alpha 5 chain, a major component of the renal extracellular matrix. Homozygous mice showed symptoms of NS including a severe proteinuria that preceded histological lesions and alteration of renal markers in plasma. Materials and Methods The Lama5 E884G mouse line was derived from a G3 pedigree produced in the MRC Harwell N-ethyl-N-nitrosourea (ENU) mutagenesis screen. The mutation was identified combining the use of a dense SNP panel and whole genome sequencing. Lama5 E884G/+ mice were then backcrossed for a total of 10 generations to C57BL/6J mice. Urine and plasma were collected at different time points and markers of kidney function were measured. Kidneys were also collected for pathological assessment and study of the molecular mechanism. Concurrently, an in vitro study is ongoing to look at the expression and secretion of LAMA5 and its interaction with other laminin chains.
Results Time course studies of Lama5 E884G homozygotes showed high levels of proteinuria from 25 weeks of age but no other signs of kidney impairment. Affected mice also have significantly elevated cholesterol levels. Alterations in the expression of genes and protein associated with integrin International Journal of Experimental Pathology, 2017, 98, A1-A14 signal-mediation show an abnormal response of the glomeruli that could possibly have an effect on the podocytes' Factin bundles. Preliminary in vitro results show an impairment secretion of LAMA5 short arm. Discussion We have identified a novel mutant mouse line exhibiting NS resulting from a point mutation in Lama5. This gene has recently been associated with renal disease in patients. We are currently dissecting the molecular pathogenesis of disease in these animals to provide insight into human disease.
Alternative splicing of tenascin-C modulates cell-matrix interactions during inflammation and disease S. P. Giblin* and K. S. Midwood* *Kennedy Institute of Rheumatology, University of Oxford, Headington, Oxford, OX3 7FY, United Kingdom Introduction Tenascin-C is an immunomodulatory extracellular matrix protein that exhibits limited expression in healthy tissues, is transiently elevated at sites of tissue injury, and is persistently expressed in chronic inflammatory diseases and tumours. Alternative splicing of tenascin-C's 9 fibronectin type III-like domains (FnIII-A1, A2, A3, A4, B, AD2, AD1, C and D) generates enormous diversity in form; yielding 511 possible isoforms. Post-transcriptional modification of tenascin-C has been studied in cancer and during development where diseaseand tissue-specific isoforms exhibit distinct adhesive, migratory and proliferative effects. However, little is known about tenascin-C expression and alternative splicing during inflammation. This study characterises inflammation-and disease-specific tenascin-C isoforms made by immune cells and fibroblasts, and investigates their functional relevance. Materials and Methods Biosynthesis and alternative splicing of tenascin-C was examined using standard curve qPCR, ELISA, Western blot and confocal immunocytochemistry in resting and activated primary human immune cells, dermal fibroblasts, and in synovial fibroblasts isolated from healthy controls and from osteoarthritis (OA) and rheumatoid arthritis (RA) patients. FnIII domains AD2-AD1, B-C-D and B-AD2-AD1-C-D were cloned, expressed and purified, and their impact on cell behaviour including adhesion and morphology was assessed. Results Basal tenascin-C expression was lower in myeloid and lymphoid cells than fibroblasts, and was induced in all following inflammatory stimulation. Tenascin-C expression was elevated in disease with RA and OA synovial fibroblasts containing higher levels than healthy controls. Alternative splicing following cell activation was cell-type specific: all FnIII except AD2 and AD1 were upregulated in dendritic cells and macrophages, in T-cells all FnIII were downregulated and A1 was absent, and no change in splicing was observed in activated dermal fibroblasts. RA and OA fibroblasts predominantly expressed smaller isoforms, with FnIII-B and D specifically elevated in RA. Functional analysis revealed differences in the adhesion and morphology of myeloid cells and dermal fibroblasts cultured on FnIII AD2-AD1, B-C-D, B-AD2-AD1-C-D and full length tenascin-C substrates.
Discussion For the first time, this study reveals differences in tenascin-C biosynthesis and alternative splicing by immune cells and fibroblasts following activation with inflammatory stimuli, and identifies cell-type specific responses to distinct FnIII domains that direct cell-matrix interactions.
Human breast cancer and decorin
A. Sainio*, P. Bostr€ om † , N. Eig elien e ‡ , I. Koskivuo § and H. J€ arvel€ ainen Introduction Certain extracellular matrix (ECM) macromolecules, particularly proteoglycans such as decorin, have been identified as one of the key players capable of modulating cell signaling, adhesion, migration, proliferation, and apoptosis. Decorin is the prototype member of the small leucine rich proteoglycan (SLRP) gene family. It is capable of interacting with different ECM macromolecules, growth factors, e.g. members of the ErbB family, and their receptors. In various types of cancer, including breast cancer, decorin 0 s expression in the tumor microenvironment (TME) has been reported to be markedly decreased. Furthermore, its reduced expression has been shown to be associated with poorer outcome in invasive breast cancer and, on the other hand, its high stromal expression predicts better prognosis. Decorin adenoviral transduction has been demonstrated to decrease the malignant behavior of breast cancer cells, and even to suppress their capability to form bone metastasis. As a summary, decorin is currently considered as an oncosuppressive molecule. The aim of our study was to explore decorin expression in different types of human breast cancer, and to test the effect of human decorin cDNA adenoviral transduction on breast cancer cells. Materials and Methods As materials, human adenocarcinoma cell line (MCF-7) and breast tissue samples (metaplastic, lobular, and ductal breast cancer) were used. Methods included immunohistochemistry, in situ hybridization (ISH), human decorin cDNA adenoviral transduction (Ad-DCN), 3D explant cultures, and RT-qPCR. Results Human breast cancer cells, independent of the type of cancer, totally lack decorin immunoreactivity and expression. Decorin is detected only in areas of original, nonmalignant stroma. Transduction of human breast cancer cells with Ad-DCN markedly alters their malignant behavior resulting in decrease in proliferation, and viability, and increase in apoptotic features of the cells both in monolayer and 3D cultures. Discussion The results of our study favor the development of novel adjuvant therapies based on decorin mediated
International Journal of Experimental Pathology, 2017, 98, A1-A14 mechanisms. Noteworthy is also the idea of 'normalization of the tumour microenvironment' whereby decorin in its part could orchestrate cancer cells towards a less malignant phenotype, and even to a less malignant behavior.
Introduction Osteoarthritis is a leading cause of disability for which there is no cure. The identification of molecules supporting cartilage homeostasis and regeneration is therefore a major pursuit in musculoskeletal medicine. Agrin is a heparan sulphate proteoglycan which we identified as an essential molecule in articular cartilage homeostasis, requiring both a-dystroglycan and LRP4 to support SOX9 expression and chondrocyte differentiation in vitro and in vivo.
Despite identifying the receptors necessary for the chondrogenic effects of Agrin in chondrocytes, the signalling pathway(s) by which this occurs remains unclear. LRP4 signalling is known to negatively regulate WNT signalling. Therefore, we tested whether Agrin is required for the WNT-inhibitory properties of LRP4 and whether this is the mechanism by which Agrin signals in chondrocytes. Materials and Methods Agrin or GFP was overexpressed in bovine primary chondrocytes and cultured in micromass in the presence or absence of 100 ng/ml WNT3A. Chondrogenic potential was assessed by qPCR for SOX9 mRNA expression. Agrin or GFP stably expressing COS7 cells were transfected with the SUPER8TOPFLASH reporter plasmid in combination with Vehicle or LRP4 plasmids. COS7 monolayer cultures were treated with vehicle or increasing doses of WNT3A. Osteochondral defects were created in 8 wk old C57 male mice and treatment of Agrin or GFP was control was delivered by collagen gel. Joints were examined by lCT and histology after 8 wks. Results LRP4 overexpression was sufficient to induce SOX9 upregulation in chondrocytes; however, this effect was abolished following Agrin knockdown demonstrating the requirement of Agrin for the chondrogenic effect of LRP4 signalling. In addition, downregulation of SOX9 mRNA expression induced by WNT3A treatment was rescued by Agrin overexpression in micromass cultures. Using the WNT reporter assay, activation of canonical WNT signalling was inhibited by Agrin; and this effect was exacerbated by overexpression of LRP4. Osteochondral defects remained present in almost all GFP treated mice; however, Agrin treated mice had a much higher rate of repair as measured by lCT and safranin O staining.
Discussion Agrin inhibits canonical WNT signalling through LRP4 and enhances chondrocyte differentiation. It is likely that the inhibition of WNT signalling induced by Agrin is responsible for the reparative capabilities displayed in our murine osteochondral defects.
Mechanical stretch and age affect fibrosis-related gene expression in lung fibroblasts. Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive debilitating disease, of unknown aetiology. Life expectancy is around 5 years after diagnosis, and there is currently no treatment that can resolve the pathology. IPF predominantly affects the elderly with 94% of those affected aged over 60 years. IPF is characterised by activation of interstitial fibroblasts, leading to excessive production of extracellular matrix (ECM). Cytokines such as TGF-ß play a critical role in driving fibrosis. It is unclear whether ageing affects the response of lung fibroblasts to cytokines and mechanical stretch.
The aim of this study was to investigate the roles of aging and mechanical stretch on ECM production by lung fibroblasts in response to TGF-ß. Materials and Methods Primary fibroblasts were isolated from the lungs of young (4 months) and old (15 months) mice. Cells seeded onto fibronectin-coated plates, were exposed to 6 h of stretch (6.6%, 1 Hz) using a Flexcell system. Gene expression was determined using quantitative RT-PCR. Results Collagen 1 (Col1a1) expression showed a significant twofold increase in aged cells compared to young cells. TGF-ß upregulated connective tissue growth factor (CCN2/ CTGF) expression four fold and collagen type 3 (Col3a1) by 25% at both ages. The stretch protocol lead to a decrease of the TGF-b stimulated CTGF levels of 14% and 29% and Col3a1 level of 55% and 31% respectively for young and old group.
We recently found that miR-21a-5p is upregulated in the Bleomycin mouse model of lung fibrosis. miR-21a-5p was downregulated by TGF-ß around 40%. Mechanical stretch abolished the effect of TGF-ß. This effect was the same in both young and old fibroblasts. Discussion We found that aging affects Col1a1 expression in lung fibroblasts, and mechanical stretching of the fibroblast inhibited at least some of the effects of TGF-ß. Our findings may partially explain why IPF predominantly affects the elderly, and the increased stiffness of the fibrotic lung may decrease the protective effects of stretching, partially explaining the progressive nature of the disease.
Introduction Collagen fibrils are permanent structures in the extracellular matrix of connective tissues but the molecular basis for their longevity has not been studied. Here we provide evidence for a chronomatrix that accounts for~3% of collagen, is replaced daily, and is preferentially susceptible to mechanical damage. We propose that the susceptibility of chronomatrix to damage by cyclic loading protects the permanent collagen during the lifetime of the animal. Materials and Methods We obtained tail tendons from 6 week old wt C57 mice and analyzed collagen fibril morphology. RT-PCR, western blotting and proteomics were used to optimize the rhythmic behaviour of genes of interest. We used CRISPR-Cas9 approach to knockdown the genes of interest. Confocal microscopy was used to observe the collagen secretion in muse embryonic fibroblasts (MEFs). Results The chronomatrix is regulated by anti-phasic expression of Sec61a2 and Mmp14. Sec61a2 expression is maximal at night and is essential for procollagen (the precursor of collagen) secretion. Expression of Mmp14 only in the day drives chronomatrix turnover. Rhythmic expression of Mia3 and Pde4d regulates anterograde and retrograde ER-Golgi trafficking of HSP47 (the procollagen chaperone), and provides a regulatory control loop for procollagen secretion. Conditional knockout of Mmp14 in adult mice leads to accumulation of a fibronectin-and collagen-rich chronomatrix resulting in fibrosis. Discussion We discuss how loss of circadian control of the matrix can lead to fibrosis and why collagen-rich tissues are predisposed to age-related degeneration. This project is funded by Wellcome Trust.
Do the sub-bundles within the Achilles tendon originating from distinct muscle bellies differ in structural and mechanical properties?
Introduction The Achilles tendon (AT) is one of the most frequently injured tendons due to its continuous exposure to high forces. It is formed of three sub-bundles originating in the muscle-bellies of the medial gastrocnemius (MG), lateral gastrocnemius (LG) and soleus (S), which together form the triceps surae. Previous studies have looked at the AT's mechanical and biochemical properties as a whole, but have not studied these properties in the separate sub-bundles. Differences between sub-bundles could predispose the tendon to injury, and an understanding of these differences may lead to the development of revised treatments. This study aims to test the hypothesis that different sub-bundles of the AT have diverse material properties as a result of different molecular composition. Materials and Methods Five fresh-frozen below-the-knee human cadaver specimens (69-87 years) were examined. A layer-by layer dissection was performed separating the triceps surae and AT. The muscle and tendon fibres were inspected under magnification and separated. The cross-sectional area (CSA) of the whole tendon and of the sub-bundles was measured prior to mechanical testing to failure. Samples of tissue from each sub-bundle were taken, and water content, collagen content, collagen-linked fluorescence, total sulphated glycosaminoglycan (GAG) and DNA content quantified. Results The CSA of the S (33.1 AE 7.0 mm 2 ) was significantly (P = 0.012) larger than that of the LG (9.6 AE 4.4 mm 2 ) and MG (13.4 AE 2.7 mm 2 ) and this corresponded to a significantly (P = 0.032) higher force at failure (1362.4 AE 406.3N), although the stiffness of the S was not significantly higher than that of the LG or MG. The mean values of material properties (failure stress and elastic modulus) and hysteresis were lower in the soleus than the LG and MG although these were not significantly different. The elastic moduli varied widely (up to 72%) between the sub-bundles of individuals. Water content of the S (66.8 AE 5.1%) was significantly higher (P = 0.042) than the LG (63.2 AE 5.0%) and MG (63.0 AE 7.0%). Discussion The results of the study reveal a complex structure with wide variation in properties between the separate bundles. Age-related changes may also be bundle specific, highlighting the need for further work with larger group sizes and a broader age range.
The role of the circadian clock regulated vacuolar protein sorting (VPS) tethering complex in procollagen secretion and cell contractility J. Chang*, R. Garva* and K. Kadler* *University of Manchester, Oxford Road, Manchester, M13 9PT, United Kingdom Introduction Deregulation of extracellular matrix (ECM) forms the basis to many pathological conditions, including fibrosis, tendinopathies, and cancer. Fibroblasts are the major cell type that produces ECM in the body; as such, understanding how ECM production and turnover is controlled in fibroblasts is key to discovering processes that could be targeted for potential therapeutics. Previously we have identified that ECM production and turnover in fibroblasts is regulated by the circadian rhythm. In particular, a International Journal of Experimental Pathology, 2017, 98, A1-A14 member of the vacuolar protein sorting (VPS) family of tethering complexes in protein sorting, VPS33b, is found to be rhythmic from RNA microarray data. VPS33b has been implicated in post-Golgi sorting of protein cargoes, as well as maturation of endosomes/lysosomes. Here, we hypothesise that VPS33b is crucial to the circadian control of both collagen I secretion and uptake. Materials and Methods Using CRISPR-Cas9, we have knockedout VPS33b expression in immortalised Per2-luc mouse tail tendon fibroblasts. Immunofluorescence (IF) staining, collagen contraction assay, scratch-wound assay, and lumicycle analyses were carried out. Results We confirmed through western blotting that VPS33b protein expression is rhythmic in mouse tail tendons. Using IF, collagen I has a higher retention rate within the Golgi complex of VPS33b knock-out (VPS33b KO) fibroblasts, and KO cells have a marked reduction in collagen fibril deposition. KO cells also have decreased contractility, and showed decreased amplitude in their circadian rhythm; however, there is no obvious change in the migratory function of VPS33b KO fibroblasts. Discussion Our data suggests that VPS33b is involved in collagen I secretion and deposition of collagen I fibrils. In addition, the effects of VPS33b KO in fibroblast functionality and circadian rhythm suggest that VPS33b may have functions in pathways not related to trafficking, or that VPS33b-regulated protein trafficking is involved in regulating fibroblastic functions. Further analyses on the effects of VPS33b KO on uptake of pre-existing collagen fibrils, as well as the mechanisms of VPS33b-regulated collagen I secretion are currently underway.
Role and regulation of PRDM8 in pulmonary fibrosis associated with systemic sclerosis
Introduction Systemic sclerosis (SSc) is a multisystem disease characterized by progressive fibrosis. There are no adequate anti-fibrotic treatments, consequently fibrosis remains an unmet clinical need. Microarray screening of lung fibroblasts identified a transcriptional repressor, PRDM8, as a potentially important regulator of fibroproliferation in SSc. Mechanisms proposed for PRDM8 regulation and function include DNA hypermethylation and formation of regulatory protein complexes. However, these have not been investigated in fibroblasts or SSc. Materials and Methods Illumina Infinium HumanHT-12 v4 Expression and Human Methylation 450 BeadChips were used to identify differentially expressed and methylated genes between fibroblasts derived from control (n = 6) and SSc (n = 7) lungs. Target gene expression was confirmed by qRT-PCR and CpG methylation validated by bisulfite sequencing. Proteins were visualized and quantitated by immunostaining and Western blotting. Results PRDM8 expression was decreased by 30-80% in SSc fibroblasts compared with controls (P = 0.003). This was validated at the protein level in another cohort of SSc fibroblasts and further confirmed immunohistochemically in control and SSc lung.
Methylation arrays revealed 20 hypermethylated PRDM8 CpGs in SSc versus controls. Bisulfite sequencing confirmed the array data and identified additional hypermethylated CpGs. However, fibroblast treatment with a DNMT inhibitor, 5-Aza-2 0 deoxycytidine, did not affect PRDM8 methylation or expression.
Based on the literature, laforin, malin and BHLHE22 were investigated as potential PRDM8-binding partners. Lung fibroblasts expressed laforin and malin, and immunostaining revealed predominant nuclear localization that was less intense in SSc versus controls. Laforin localization in lung tissue was similar to PRDM8, with weak or undetectable nuclear staining of fibroblast-like cells in SSc lung, whereas malin was ubiquitously distributed. BHLHE22 was not detectable, however BHLH family members, BHLHE40 and BHLHB9 were expressed. Discussion We have demonstrated that PRDM8 is hypermethylated and down-regulated in SSc lung but CpG hypermethylation does not appear to be responsible for its decreased expression. Additionally, we identified laforin, malin, BHLHE40 and BHLHB9 as potential fibroblast PRDM8 binding partners. Further studies are required to characterize their association with PRDM8 and functional role. The lack of fibroblast BHLHE22 expression suggests PRDM8 transcriptional complexes may be cell/tissue specific. If confirmed, this would provide potential for selective and specific therapeutic targeting.
Introduction Osteoarthritis (OA) is a multicomponent disease characterized by articular cartilage degeneration, but also affecting surrounding tissue including the ligaments. Ligaments, made up of dense connective tissue with an extensive extracellular matrix, are responsible in stabilizing the joint and guiding motion. Trauma to the ligament has been closely linked to OA in humans and in animal models (PondNuki model, and destabilization of the medial meniscus (DMM)). The goal of this study was to understand the pathology of changes in the ligaments during disease progression in murine spontaneous and posttraumatic OA.
International Journal of Experimental Pathology, 2017, 98, A1-A14 Materials and Methods Histological sections were taken from mouse knee joints of three different OA models: STR/ort mice, C57Bl/6 mice following DMM surgery, and CBA mice following non-invasive knee trauma. Samples were imaged for microCT and then stained with Toluidine Blue for pathophysiological changes. Immunohistochemistry (IHC) was performed on the non-invasive knee trauma model at 4 and 14 weeks post-trauma and STR/ort mice at three stages: grade 1-2, 3-4, and 5-6 (OARSI grading system); markers included cartilage matrix (collagen type II, aggrecan, and sox9) and chondrocyte hypertrophy (runx2). Results Toluidine Blue staining showed changes in the ligaments that were consistent with endochondral ossification, including increased extracellular matrix staining, loss of fiber alignment, and cell hypertrophy near attachment sites. MicroCT of the joint space revealed an increase in mineralized tissue volume with increasing severity of OA grades in STR/ort mice and also in response to DMM surgery and non-invasive trauma. IHC demonstrated modification particularly in collagen type II and sox9 expression. In the trauma model, results included collagen type II deposition in the mid-ligament region along with sox9 expression. Meanwhile in the STR/ort models, collagen type II deposition was found only in the tibial attachment site of the ligaments. Hyperplasia and cell hypertrophy in the attachment sites correlated to expression of sox9 and runx2 in both OA mice models. Discussion Overall, ligament pathology is affected during OA progression, and pathology changes are consistent with chondrogenesis and potentially endochondral ossification. The full extent of these changes in the ligament matrix along with the consequences to ligament function and OA remains to be seen.
Exploring age-related changes to the putative tendon stem cell niche Introduction Tendon injury adversely affects health and performance, particularly with ageing. Most injuries occur to the highly-strained, energy storing human Achilles tendon and equine superficial digital flexor tendon (SDFT). This high-strain capacity is enabled by specialisation of the interfascicular matrix (IFM), which binds, and allows sliding between, tendon fascicles. Ageing alters IFM properties and reduces the reparative and mechanical capacity of tendon. Current treatments remain ineffective, yet emerging evidence has identified a population of CD146 + tendon stem/progenitor cells (TSPC) which could be harnessed for therapies. Here, we interrogate whether the IFM serves as a stem cell niche, and how ageing IFM affects the TSPC population.
Materials and Methods SDFT sections from young (3-8 years, n = 5), middle-aged (10-15 years, n = 5), and old (18-25 years, n = 5) horses were immunofluorescently labelled for stem cell markers (CD44/CD146). In addition, tendonderived cells, enzymatically isolated from young (n = 1) and old (n = 1) SDFTs were analysed by immunocytochemistry and flow cytometry for CD44, CD90, and CD146. Results Image analysis of fluorescently-labelled sections showed CD146 + cells are predominantly localised to the IFM compared to non-IFM (P < 0.0001), with no change in distribution across age groups. Ageing was associated with a decline in prevalence of CD44 + cells within non-IFM regions (middle-aged, P = 0.0019 and old, P < 0.0001 compared to young) but not within the IFM. Immunocytochemistry demonstrated that most isolated tendon cells express CD44, CD90, and Mohawk, but fewer expressed CD146. Flow cytometry confirmed that young and old tendon cell populations were CD44 + (>95.5%), CD90 + (>85.1%), with small subpopulations of CD146 + (<5.8%).
Discussion We have demonstrated that a population of CD146 + cells reside within the IFM, indicating that it may represent a putative tendon stem cell niche. Surprisingly, CD44
+ cell numbers in the non-IFM regions show an agerelated decline, but despite no significant effect of ageing on CD146 + cell numbers, the observed reduction in labelling intensity with ageing requires further investigation. Future studies will aim to characterise CD146 + TSPCs which coexpress and/or colocalise with known stem cell markers. This will determine whether differentiation potential and reparative capacity of TSPCs are affected by ageing and identify strategies to promote more efficient intrinsic repair.
Introduction It is well known that the risk of tendon injury increases with increasing chronological age suggesting agerelated changes to the structure and composition of tendon. Energy storing tendons, such as the Achilles tendon, are particularly prone to injury while others, such as the anterior tibialis tendon, which has a positional role, are rarely injured. It has been well documented in the horse that tendons with different functional requirements differ in their material properties and composition and that changes occur with ageing, however less information is available for human tendons. The aim of this study was to test the hypothesis that ageing human tendons show signs of fibre disorganisation and reduced cellularity, which are more pronounced in the high-strain energy-storing Achilles tendon than the positional anterior tibialis tendon.
Materials and Methods Human Achilles and anterior tibialis tendon samples were collected from a young (aged 14-21 years, n = 6) and an old group (aged 65-81 years, n = 6) of donors. Longitudinal sections were cut and stained for histological assessment. Total cellularity, cell morphology and collagen fibre width were measured using image analysis software. Results Collagen fibre width was 22.15 lm AE 7.60 and 19.10 lm AE 3.25 for the Achilles and anterior tibialis tendons respectively and did not differ between tendon types or age groups. Total cell number was significantly higher in the energy-storing Achilles tendon (95.72 AE 26.55) than the anterior tibialis (43.67 AE 16.06), in line with findings in equine tendons. Discussion The proportion of elongated and rounded cells did not differ between tendon types however the rounded cells in the Achilles tendon samples were significantly larger than those in the Anterior tibialis samples. The total cell population was lower in the old group of anterior tibialis tendons compared to the young group, whereas there was no significant difference between age groups for the Achilles tendon. The old group of Achilles tendons had significantly more rounded cells than the old group of anterior tibialis tendons. These results suggest that the capacity for matrix turnover and repair does not decrease in old Achilles tendon and implicate other mechanisms for age-related tendinopathies.
IL-31 is elevated in scleroderma and promotes multiple pathogenic mechanisms leading to skin fibrosis Introduction In systemic sclerosis (SSc) Th2 cytokines provide a possible mechanistic link between autoimmunity and the fibrotic pathology seen. IL31 is a recently described Th2 cytokine which signals via the oncostatin M receptor/IL-31RA dimer. We sought to determine whether IL-31 is elevated in SSc plasma or blister fluid (BF), and test whether the IL-31RA is expressed by cells relevant to the disease process. Responses of target cells to IL-31 were evaluated. Furthermore, in a mouse model IL-31 was delivered subcutaneously with or without additional TGFb, and the fibrotic response assessed. Materials and Methods IL-31 was measured by ELISA of plasma (SSc n = 43, HC n = 27) and BF (SSc n = 44, HC n = 22). Itch severity was determined by the 5D pruritus scale. IL31RA mRNA was assayed by qPCR of SSc and HC fibroblasts, epidermal tissue extracts, and fat derived MSCs. Responses of target cells to IL-31 were measured by next generation sequencing. Wild type C57/B6 mice were treated with subcutaneous IL-31 200 ng/day, with or without TGFb 800 ng/ml for 14 days, and then euthanised at 21 days Results Plasma IL-31 was elevated in SSc (HC 0-792, median 55, IQR 0-375, SSc 0-17764, median 193, IQR 13-658 pg/ ml, P < 0.048), and BF IL-31 trended towards elevation in SSc (HC 0-2777, median 0, IQR 0-23, SSc 0-38222, median 0, IQR 0-175 pg/ml, pNS). IL-31RA, was expressed by multiple target cells relevant to the fibrotic process. Treatment of skin fibroblasts with IL-31 induced gene expression profiles linked to integrin signalling, growth, actin polymerisation, motility, plus Wnt and TGFb signalling, and induced phenotypic changes including migration and collagen protein release, resembling the activation state in the disease. MSCs derived from subcutaneous fat were stimulated to migrate and differentiate by IL-31. In mice, IL-31 induced skin fibrosis more than the known pro-fibrotic TGFb, and led to increased cytokine and growth factor levels in a scleroderma-like pattern (increased skin collagen on PSR, P < 0.03, raised plasma IL-6 P < 0.03). Discussion IL-31 is increased in SSc, induces phenotypic and gene expression changes in target cells, and leads to skin fibrosis in mice, consistent with a pathogenic role in scleroderma, distinct from and additive to TGFb.
Introduction Prolyl 3-hydroxylase enzymes modify prolines in certain sequences in the C-terminal helical region of procollagens converting them to 3-hydroxyproline residues, which facilitates correct alignment of the chains in forming the triple helical domains of the procollagen molecules prior to secretion. Over production of triple helical collagen and other extracellular matrix (ECM) proteins by activated fibroblasts underlies pathological fibrosis and may be dependent on prolyl 3-hydroxylase activity as a rate-limiting step. Materials and Methods A PCR based methodology was used to screen candidate genes relevant to fibrosis with large regulatory first intron sequences for CNV for possible association with scleroderma susceptibility. Furthermore, SNP and haplotype analysis was used to further investigate scleroderma associations of positive hits from the initial screen. The biology of an identified candidate gene LEPREL1 was investigated by genetic deletion in a mouse model, as well as CRSPR/Cas9 silencing in human pathologic fibroblasts. Results CNVs with SMAD binding sequences in the first intron of the LEPREL1 gene, encoding prolyl 3-hydroxylase 2, were identified in the DNA from 47 out of 48 male patients but not statistically linked to scleroderma in female patients. However, sequence analysis of the first intron in LEPREL1 in female patients identified a FOXA1 site in the gene responsive to estrogen which enhanced collagen synthesis by cultured fibroblasts. LEPREL1 protein levels were elevated in dermal fibroblasts from scleroderma patients and were induced to similar levels in normal cells by TGFb, a pro-fibrotic growth factor. Deletion of the LEPREL1 gene in mice was protective against bleomycin-induced dermal fibrosis, and CRSPR/Cas9 silencing of the LEPREL1 gene in scleroderma fibroblasts reduced basal collagen I secretion and blocked induction by TGFb. Discussion Genetic variants in LEPREL1 are associated with risk of scleroderma development and the encoded prolyl 3-hydroxylase enzyme has an important role in pathologic fibrosis and represents a target for therapy.
Progranulin and derivatives can be employed as latent dual-function chondrogenic and anti-inflammatory therapeutics for the treatment of arthritis Introduction Cartilage and bone matrices are catabolised in diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA). Current treatments for these diseases often focus on pain relief or treatment of the causative and resulting inflammation. These approaches can reduce disease progression, but are rarely effective at reversing joint damage. Additionally, these medications are typically administered systemically which can result in undesirable off-target side effects. The latency-associated peptide (LAP) of TGF-b1 sterically hinders interactions between the active cytokine and its receptors until mechanical, integrin-mediated or pHdependent release. Fusing LAP to the N-terminus of various cytokines via a matrix metalloproteinase (MMP) cleavable site has conferred latency to them until reaching sites of high MMP activity such as arthritic joints. Progranulin (PGRN) is a chondrogenic factor with anti-inflammatory properties, and by targeting it to diseased joints by fusion to LAP could reduce immune-mediated damage and additionally promote extracellular matrix (ECM) regenerationwithout triggering off-target effects. Materials and Methods Micromass cultures of C28/I2 chondrocytes and C3H10T1/2 mesenchymal cells were employed to determine the ability of PGRN to stimulate chondrogenesis. HT-29 and WEHI-164 tumour necrosis factor (TNF) sensitive cells were used to evaluate the anti-TNF capacity of PGRN. Fibroblasts transduced with lentivirus encoding LAP-PGRN fusions were delivered to collagen-induced arthritis (CIA) mice to assess anti-arthritic effects. Results PGRN, LAP-PGRN, and LAP-PGRN mutants were expressed in mammalian expression systems. PGRN elevated sulphated proteoglycan production in micromass cultures of C28/I2 human chondrocytes, and stimulated proliferation of C3H10T1/2 cells. Furthermore, PGRN reduced TNFmediated catabolism of ECM in established chondrogenic C3H10T1/2 micromass cultures. LAP-PGRN and LAP-PGRN mutants potentiated BMP2-mediated chondrogenesis in C3H10T1/2 micromasses. PGRN failed to prevent TNFmediated cytotoxicity in multiple cell assays, as did LAP-PGRN, after in vitro MMP1 cleavage and release of PGRN. CIA progression was reduced in DBA/1 mice treated with autologous fibroblasts overexpressing murine Etanercept or PGRN relative to control treatment. LAP-Atsttrin (a LAP-PGRN mutant) was effective at ameliorating CIA relative to LAP-Empty controls. Discussion PGRN could be used as a targeted dual-function chondrogenic and anti-inflammatory treatment for arthritis, but these effects are not elicited directly through the TNF pathway.
Introduction The differentiation of human bone marrowderived mesenchymal stem cells (MSCs) along several pathways can be modulated by external biophysical cues. The aim of this study is to investigate the effects of uniaxial tensile strain and MSC differentiation on nuclear shape changes and their association with H3K27me3 epigenetic gene silencing. Materials and Methods MSCs undergoing osteogenic (OM), adipogenic (AM) or chondrogenic differentiation with (CM+) or without (CM-) transforming growth factor-b3 (TGF-b3) on silicone substrates were exposed to 3% uniaxial dynamic tensile strain at 1 Hz for 6 h/day for 1 (6 h) or 3 (3 9 6 h) days. After strain application, MSCs were fixed and stained for DNA, f-actin, linker of nucleoskeleton and cytoskeleton (LINC) complex component SUN2 and H3K27me3. Images were analysed for nuclear shape, orientation and fluorescent stain intensity using a custom script in MATLAB.
Results While 6 h of strain led to modest increases in nuclear projected area, 3 9 6 h significantly increased nuclear projected area in all conditions by 20%-50%. The increase in nuclear area was associated with a significant increase (50%-150%) in f-actin intensity in the region of the nucleus. SUN2 plays a key role in connecting the nucleus to the cytoskeleton. While SUN2 levels were increased in chondrogenic differentiation (CM-), SUN2 levels throughout the nucleus decreased for all conditions in response to strain (3 9 6 h). As SUN2 was measured throughout the nucleus, this observed decrease in mean intensity may be a result of a reorganisation of SUN2 into a cortical shell at the nuclear periphery. We finally investigated whether strain-induced changes in nuclear shape had any functional consequences for epigenetic signalling associated with differentiation. H3K27me3 was upregulated in osteogenic (OM), adipogenic (AM) and chondrogenic (CM+) differentiation. However, strain (3 9 6 h) significantly reduced H3K27me3 levels.
Discussion Increased f-actin intensity in the nuclear region is consistent with increased apical actin stress fibres and a reduction in nuclear height which may explain the observed increase in nuclear projected area. This nuclear shape change is correlated with a reduction in H3K27me3. Further work is required to elucidate the mechanism through which nuclear shape change leads to changes in the epigenetic signature of differentiating MSCs.
Introduction Collagen accounts for 30% of body mass where it functions as a major tissue scaffolding protein and stressshields cells from destructive mechanical forces. Dysregulation in the amount of collagen is associated with fibrosis and tissue degenerative. Understanding how collagen is produced, processed and regulated is key to developing new treatment strategies for these diseases. A major technical hurdle has been the absence of a robust method to quantitatively assess the impact of therapeutics on the production of newly formed collagen. Materials and Methods We have generated mouse 3T3 cells that have been modified using CRISPR/Cas9 to integrate a Dendra2 fluorescent fusion protein downstream of the signal peptide of the pro-alpha2(I) chain of type I procollagen. This approach maintains the natural context of the genomic structure, ensuring the gene expression patterns are faithfully recapitulated. Dendra2 is photoswitchable, which naturally fluoresces green, until exposed to 405 nm light, which converts the reporter to a red fluorescent protein. With this approach we can selectively remove the background collagen signal, and then image or assay specifically for the production of new 'green' collagen. Intracellular trafficking of procollagen can be monitored and the turnover of photoswitched Dendra2 collagen provides information on the dynamics of collagen turnover. Results Our first result shows that procollagen is formed on a daily basis and can be observed within the Golgi apparatus for approximately 3 h. This approach allows measurement of the dynamics of procollagen translation and vesicle secretion whilst under endogenous control mechanisms. This approach also allows visualisation of Dendra2-collagen fibres, which form following 4 days in culture in the presence of L-ascorbic acid. Fibres are formed close to the cell boundary and cells then migrate away from the fibrils. Individual cells were able to produce multiple fibres. The vast majority (>95%) of collagen fibrils remain stable for up to 7 days; however some fibrils are broken down over the course of 24 h. Discussion In conclusion, CRISPR/Cas9 technology has enabled us, for the first time, to image live fibroblasts synthesising collagen fibres at the cell-matrix interface. This technology is likely to be applicable to the study of other fibril-forming collagens and matrix macromolecules.
Introduction Collagen accounts for 30% of body mass where it functions as a major tissue scaffolding protein and stress shields cells from destructive mechanical forces. Levels of collagen remain remarkably constant during the lifetime of an animal except in chronic diseases such as tendinopathy, osteoarthritis and fibrosis. Thus, extensive evidence points to the existence of a homeostatic mechanism, however, none has been found. Our group has shown that collagen homeostasis is regulated by the circadian clock in which the synthesis and degradation of collagen are separated into different times of the day (manuscript submitted). Materials and Methods Microarray profiling of mouse tendon over two days identified numerous regulators of collagen biosynthesis. One transcript encoded Bip/Grp78/Hspa5. Bip is a chaperone protein that aids the folding of collagen and is the master regulator of the unfolded protein response (UPR). In response to unfolded proteins Bip translocates from the ER membrane to the ER lumen thereby releasing its inhibitory effects on the IRE1, PERK and ATF6 arms of the UPR. We have examined the impact of ER stress on the production of collagen and circadian rhythm. Results Activation of ER stress inhibited the circadian rhythm in fibroblasts, and also inhibited the production of collagen. In order to suppress activation of the unfolded protein response, Bip was overexpressed in tail tendon fibroblasts isolated from the Per2-luciferase mouse. Bioluminescence measurements showed that exogenous Bip increased the amplitude of Per2 expression and strengthened the circadian rhythm. In a similar manner, addition of the molecular chaperone 4-phenylbutyrate (4-PBA) also enhances circadian rhythms. Others have reported that IRE1-XBP1 and ATF6 target genes are modulated by day/ night cycles; our findings suggest that by resolving endogenous ER stress, circadian rhythm can be enhanced and that unresolved ER stress suppresses the activation of Per2 and the circadian rhythm. Induction of ER stress was able to suppress the secretion of collagen, as did exogenous expression of Bip. Discussion We propose that modulation of ER stress and the UPR could aid in the treatment of chronic diseases such as tendinopathy, osteoarthritis and fibrosis via normalisation of circadian rhythms and reestablishment of normal collagen homeostasis.
Introduction Dendritic cell-lymphocyte interactions orchestrate the generation of the adaptive immune response within the lymph nodes (LNs). For this function, LNs require a highly-organized tissue architecture supported by different non-hematopoietic stromal cell populations. Fibroblastic reticular cells (FRCs) comprise the most abundant LN stromal cell and are characterized by expression of podoplanin (PDPN). FRCs produce and enwrap the conduit, a tubular network of collagens and other matrix components that controls intranodal flow of small antigens and secreted factors. LNs expand 3-5 times in size with each immune response. Migratory DCs expressing the C-type lectin receptor CLEC-2 control contractility of the FRC network, allowing initial expansion of the LN. Here, we study that leukocyte-stromal interactions also regulate remodelling of the extracellular matrix of LNs. Materials and Methods We characterized atrophy of skindraining LNs from aged mice in which CLEC-2 expression is depleted in DCs (CD11c DCLECÀ2 ) using flow cytometry and histology. Phosphoproteomic and transcriptomic analysis revealed that CLEC-2 binding to PDPN+ FRCs significantly altered both signaling cascades controlling matrix deposition and expression of matrix components. Conduit network integrity was studied in vitro and ex vivo by immunofluorescence.
Results CD11c
DCLECÀ2 LNs are atrophic, fibrotic-like and exhibit increased T cell:FRC ratio. RNAseq revealed that FRCs express >400 matrisome genes, of which nearly 40% were regulated by CLEC-2/PDPN interactions, including downregulation of Col6a1, Col6a2, Col4a5 and Col4a6. In FRC-derived 3D matrices in vitro, CLEC-2 treatment reduces total matrix deposition and modifies fibre bundling and alignment. Histological analysis of draining LNs after immunization shows a marked reduction in collagens within the conduit network. Phosphoproteomic analysis shows CLEC-2/PDPN-dependent modulation of proteins associated to intracellular cargo transport and microtubule attachment to the plasma membrane. Discussion Our data demonstrate that FRCs respond to CLEC-2 binding by downregulating the expression and deposition of extracellular components found in the conduit network. This correlates with observations in draining LNs after immunization. Loss of fibrilar components may reduce organ stiffness and therefore facilitate rapid LN expansion. It is therefore likely that, function of the conduit network will be compromised during the onset of the immune response.
Chemical chaperones as a therapeutic avenue for collagen IV mutations involved in brain haemorrhage and stroke A. Dean*, L. Murray*, A. Aman*, F. Jones*, S. McNeily*, W. Holmes* and T. Van Agtmael* *Glasgow University, Glasgow, G12 8QQ, United Kingdom Introduction Collagen IV is a major protein component of the basement membrane (BM) and mutations in collagen IV alpha chains 1 and 2 (COl4A1, COL4A2) cause Mendelian forms of eye, kidney and cerebrovascular disease including intracerebral haemorrhage. Recently, COL4A2 has also been identified as a risk factor for intracerebral haemorrhage in the general population. Intracerebral haemorrhage and COL4A1/4A2 pathologies remain incurable.
COL4A1/4A2 mutations cause BM defects and intracellular collagen IV retention in the endoplasmic reticulum (ER). The latter induces ER stress and activation of the unfolding protein response (UPR).
We aim to investigate the in vivo efficacy of FDA approved compounds that target the ER stress as a therapeutic approach for collagen IV disease and intracerebral haemorrhage. Materials and Methods We employed Col4a1+/SVC mice that carry a glycine to aspartic acid mutation (G1064D) in the collagen Gly-X-Y repeat, equivalent to >85% of mutations identified to date in patients. The chemical chaperones Phenyl butyric acid (PBA: 1 g/KG/24 h) and TUDCA (500 mg/ kg/day) were administered daily to animals orally via drinking water and oral gavage, respectively. We examined the efficacy of these compounds in being able to prevent and/or treat collagen IV associated pathologies. ICH was measured quantitatively by histopathology and magnetic resonance imaging (MRI). Results Our results indicated that preventative PBA treatment improved neonatal viability of mutant mice, and reduced adult intracerebral haemorrhaging and haematuria. In addition, PBA was able to reduce existing ICH. As PBA has multiple activities in addition to being a chemical chaperone, we performed TUDCA which also increased viability of pups at birth and caused a decrease in bleed volume in the preventative treatment group. We found limited effects on the eye and kidney. PBA treatment was associated with reduced ER stress levels and increased secretion of collagen IV. Discussion These data suggests that chemical chaperones can reduce the severity of ICH due to collagen IV mutations by reducing ER stress and increasing collagen incorporation into the BM. Interestingly, the tissue specific outcomes of chemical chaperone treatment provides direct evidence for tissue specific disease mechanism of collagen IV, and requirement for future treatment to target both matrix and intracellular defects.
